Latest Us Market News

Ovanti Limited has secured board approval for its ambitious US market entry plan targeting $500 million in total transaction volumes within two years, focusing on underserved consumers in the Southern States.

The a2 Milk Company delivered solid first-half FY25 results with revenue up 10.1% and net profit rising 7.6%, driven by strong growth in China and the USA despite supply constraints and ANZ challenges. The company also declared its first-ever interim dividend and upgraded its full-year outlook.

The a2 Milk Company has reported robust first-half FY25 results, boosting full-year guidance and declaring its inaugural dividend, underscoring confidence in its growth trajectory.

Artrya Limited has launched a A$15 million capital raising to fund the development and commercial rollout of its Salix AI-powered coronary artery disease diagnostic platform, targeting the lucrative US healthcare market.

Cochlear Limited posted a 6% increase in HY25 sales revenue driven by strong implant sales but anticipates FY25 profits at the lower end of guidance due to declining services revenue and rising cloud investments.

Cochlear Limited has reported a robust half-year performance with a 7% increase in underlying net profit and an 8% rise in interim dividends, driven by strong sales in cochlear and acoustic implants despite a decline in services revenue.

Hancock & Gore Limited (ASX: HNG) showcased a transformative year at its 121st AGM, spotlighting a strategic merger with Schoolblazer that creates a leading global uniforms platform and signals a new phase of growth and portfolio simplification.

Pro Medicus has delivered a record first half in FY25, driven by strong revenue growth, major contract wins, and successful implementations that position it well for future expansion.

Ionic Rare Earths Limited has signed a non-binding MOU with South Korea's DNA Link to collaborate on rare earth magnet recycling and supply, marking a strategic push into Asia and the US markets.

Treasury Wine Estates delivered a robust 1H25 performance driven by luxury brands Penfolds and DAOU, offsetting softness in its premium and commercial portfolios. Despite strong earnings growth, the company lowers its full-year EBITS guidance, highlighting ongoing market headwinds.

Amotiv Limited reported a modest 2.3% revenue increase in the first half of FY25, underpinned by acquisitions and strategic initiatives despite organic revenue softness and margin pressures. The company anticipates a stronger second half driven by new business wins and pricing actions.

Amotiv Limited posted a modest 2.3% revenue increase for H1 FY25 despite a 35.8% plunge in net profit after tax, driven by impairments and restructuring. The company signals optimism for FY25 growth, underpinned by new product launches and disciplined cost management.